Description

7-Chloro-4-Methoxy-n-(Pyridin-3-Ylmethyl)Benzo[D]Thiazol-2-Amine is a high-purity, advanced pharmaceutical intermediate featuring a complex benzothiazole core structure. This compound is critical for research and development in medicinal chemistry, particularly in the synthesis of novel small-molecule therapeutics. It is primarily utilized by pharmaceutical R&D laboratories and fine chemical manufacturers engaged in developing targeted drug candidates.

Application

• Pharmaceutical Intermediate: A key building block in the synthesis of novel drug candidates targeting various therapeutic areas.
• Medicinal Chemistry Research: Used in structure-activity relationship (SAR) studies and lead optimization for new chemical entities.
• Kinase Inhibitor Development: Serves as a core scaffold or precursor in the development of potential kinase inhibitors due to its benzothiazole and pyridine motifs.
• Chemical Biology Probes: Employed in the creation of molecular probes for studying biological pathways and target validation.
• Custom Synthesis: A starting material for contract research organizations (CROs) and CDMOs performing bespoke synthesis for client projects.
• Academic Research: Utilized in university and institutional labs for exploratory research in organic synthesis and bioorganic chemistry.

Basic Information

Product Name	7-Chloro-4-Methoxy-n-(Pyridin-3-Ylmethyl)Benzo[D]Thiazol-2-Amine
CAS No.	1105194-29-3
Molecular Formula	C14H12ClN3OS
Molecular Weight	305.78 g/mol
Synonyms	7-Chloro-4-methoxy-N-[(pyridin-3-yl)methyl]-1,3-benzothiazol-2-amine; 2-Amino-7-chloro-4-methoxy-N-(3-pyridinylmethyl)benzothiazole; 1105194-29-3; Benzo[d]thiazol-2-amine, 7-chloro-4-methoxy-N-(3-pyridinylmethyl)-; 7-Chloro-4-methoxy-N-(pyridin-3-ylmethyl)benzo[d]thiazol-2-amine; N-(3-Pyridylmethyl)-7-chloro-4-methoxy-2-benzothiazolamine
EINECS	Contact for details

Quality Control

Our products undergo rigorous quality testing to ensure compliance with industry standards. Each batch is characterized and controlled using advanced analytical techniques including HPLC, GC, NMR, and mass spectrometry to confirm identity, purity, and consistency. Certificates of Analysis (COA) with detailed chromatographic data are available upon request. We adhere to cGMP guidelines for the manufacture of advanced pharmaceutical intermediates.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated place at a controlled room temperature (typically 15-25°C). This material is moisture-sensitive (hygroscopic); keep the container tightly sealed under an inert atmosphere if necessary. Keep away from incompatible materials.

Specification

Item	Specification
Appearance	White to off-white crystalline powder
Identification (HPLC)	Conforms
Identification (IR)	Conforms to reference spectrum
Purity (HPLC)	≥ 98.0%
Water Content (KF)	≤ 0.5%
Residue on Ignition	≤ 0.1%
Heavy Metals	≤ 20 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.